Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.

Donald C SimonsonFlorencia HalperinKathleen FosterAshley VernonAllison B Goldfine

Published in: Diabetes care (2018)

Three years after randomization to RYGB versus IMWM, surgery produced greater weight loss, lower HbA1c, reduced cardiovascular risk, and improvements in obesity-related quality of life in obese patients with type 2 diabetes.

Keyphrases

weight loss
roux en y gastric bypass
bariatric surgery
gastric bypass
minimally invasive
coronary artery bypass
glycemic control
obese patients
weight gain
surgical site infection
physical activity
adipose tissue
insulin resistance
percutaneous coronary intervention
skeletal muscle
body mass index
drug induced